Pain is a uniquely complex problem. As many of us know, pain does not discriminate. It’s personal. It’s subjective and it affects everyone differently. Pain is also an incredibly challenging area to research because of how subjective it can be. Investigational programs for innovative pain treatments have one of the highest clinical trial failure rates of any major disease state. New advances in digital health may offer scientists the ability to gain more insight on the course of pain. On this episode, Joe talks to health policy advocate and entrepreneur, Seth Ginsberg. Hear what factors led him to co-found CreakyJoints, the first online patient community for people suffering from arthritis. Joe also talks to one our of own Lilly scientists, Dr. Mark Mintun, about why pain has proven to be such a challenging area to research.